Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 0.58 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.58 |
| ▸ | DRD3 | P35462 | 6/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.56 |
| ▸ | DRD2 | P14416 | 3/20 | 0.56 |
| ▸ | DRD4 | P21917 | 4/20 | 0.52 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7170172 | 0.91 | SIGMAR1 (0.57) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7170168 | 0.90 | SIGMAR1 (0.56) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7170938 | 0.89 | ABCG2 (0.62) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7167644 | 0.88 | ABCG2 (0.59) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7169868 | 0.86 | MEN1 (0.58) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7171681 | 0.85 | SIGMAR1 (0.69) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL9433141 | 0.84 | ABCB1 (0.69) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7167556 | 0.84 | SIGMAR1 (0.58) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7171661 | 0.83 | DRD3 (0.58) | ABCB1ABCG2DRD3SIGMAR1DRD2 | |
| SCHEMBL7170330 | 0.83 | DRD3 (0.53) | ABCB1ABCG2DRD3SIGMAR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934276-B1 | ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS | XENOVA LTD (GB) | 2003-12-17 | — | — | EP | claimed |
| US-6218393-B1 | IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG | XENOVA LIMITED (GB) | 2001-04-17 | — | — | US | claimed |
| EP-0934276-B1 | ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS | XENOVA LTD (GB) | 2003-12-17 | — | — | EP | disclosed |
| US-6218393-B1 | IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG | XENOVA LIMITED (GB) | 2001-04-17 | — | — | US | disclosed |
| CN-1241181-A | Pharmaceutical compounds | XENOVA LTD (GB) | 2000-01-12 | — | — | CN | disclosed |